Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Union Stem Cell & Gene Engineering is a leading Chinese biotechnology company specializing in the storage, research, and clinical application of stem cells. The company operates the Tianjin Cord Blood Bank, one of the largest and most established cord blood storage facilities in China, providing high-quality hematopoietic stem cell resources for clinical transplantation. Beyond storage, the firm is actively involved in the development of cell-based therapies and gene engineering technologies aimed at treating hematological disorders and advancing regenerative medicine. It serves as a critical infrastructure provider for the Chinese cell therapy industry through its integrated R&D and manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Union Stem Cell & Gene Engineering.